Type 3 deiodinase activation mediated by the Shh/Gli1 axis promotes sepsis-induced metabolic dysregulation in skeletal muscles

Abstract

Background: Non-thyroidal illness syndrome is commonly observed in critically ill patients, characterized by the inactivation of systemic thyroid hormones (TH), which aggravates metabolic dysfunction. Recent evidence indicates that enhanced TH inactivation is mediated by the reactivation of type 3 deiodinase (Dio3) at the tissue level, culminating in a perturbed local metabolic equilibrium. This study assessed whether targeted inhibition of Dio3 can maintain tissue metabolic homeostasis under septic conditions and explored the mechanism behind Dio3 reactivation. Methods: A retrospective clinical study was conducted to investigate the attributes of rT3. The expression of Dio3 was detected by immunoblotting, immunofluorescence, and immunohistochemical staining in tissues extracted from CLP-induced septic rats and human biopsy samples. In addition, the effect of Dio3 inhibition on skeletal muscle metabolism was observed in rats with targeted Dio3 knockdown using an adeno-associated virus. The effectiveness of Sonic hedgehog (Shh) signaling inhibition on systemic TH levels was observed in CLP-induced septic rats receiving cyclopamine. The mechanisms underlying such inhibition were explored using immunoblotting, RNA-seq, and chromatin immunoprecipitation–qPCR assays. Results: The main product of Dio3, rT3, is strongly associated with organ function. Early sepsis leads to significant upregulation of Dio3 in the skeletal muscles and lung tissues of septic rats. The targeted inhibition of Dio3 in skeletal muscle restores TH responsiveness, prevents fast-to-slow fiber conversion, preserves glucose transporter type 4 functionality, and maintains metabolic balance between protein synthesis and proteolysis, which leads to preserved muscle mass. The reactivation of Dio3 is transcriptionally regulated by the Shh pathway induced by the signal transducer and activator of transcription 3. Conclusions: The suppression of Dio3 restores tissue TH actions, attenuates proteolysis, and ameliorates anabolic resistance in the skeletal muscles of septic rats, thereby improving local metabolic homeostasis. Our results provide insights into the mechanisms of Dio3 reactivation and its critical role in local metabolic alterations induced by sepsis, while also suggesting novel targets aimed at ameliorating tissue-specific metabolic disorders.

Keywords

Type 3 deiodinase / Non-thyroidal illness syndrome / Sepsis / Sonic hedgehog / Muscle wasting

References

[1] Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014; 94: 355-82. https://doi.org/10.1152/physrev.00030.2013.

[2] Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015; 3: 816-25. https://doi.org/10.1016/S2213-8587(15)00225-9.

[3] Wang F, Pan W, Wang H, Wang S, Pan S, Ge J. Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care. 2012; 16: R11. https://doi.org/10.1186/cc11151.

[4] Fliers E, Boelen A. An update on non-thyroidal illness syndrome. J Endocrinol Investig. 2021; 44: 1597-607. https://doi.org/10.1007/s40618-020-01482-4.

[5] Knuth CM, Auger C, Jeschke MG. Burn-induced hypermetabolism and skeletal muscle dysfunction. Am J Physiol Cell Physiol. 2021; 321: C58-c71. https://doi.org/10.1152/ajpcell.00106.2021.

[6] Gunst J, Casaer MP, Preiser JC, Reignier J, Van den Berghe G. Toward nutrition improving outcome of critically ill patients: how to interpret recent feeding RCTs? Crit Care. 2023; 27: 43. https://doi.org/10.1186/s13054-023-04317-9.

[7] Fröhlich E, Wahl R. Physiological role and use of thyroid hormone metabolites-potential utility in COVID-19 patients. Front Endocrinol. 2021; 12: 587518. https://doi.org/10.3389/fendo.2021.587518.

[8] Lechan RM, Fekete C. Central regulation of hypothalamic-pituitary-thyroid Axis under physiological and pathophysiological conditions. Endocr Rev. 2014; 35: 159-94. https://doi.org/10.1210/er.2013-1087.

[9] Capelli V, Diéguez C, Mittag J, López M. Thyroid wars: the rise of central actions.Trends Endocrinol Metab. 2021; 32: 659-71. https://doi.org/10.1016/j.tem.2021.05.006.

[10] Bloise FF, Santos AT, de Brito J, de Andrade CBV, Oliveira TS, de Souza AFP, et al. Sepsis impairs thyroid hormone Signaling and mitochondrial function in the mouse diaphragm. Thyroid. 2020; 30: 1079-90. https://doi.org/10.1089/thy.2019.0124.

[11] Bianco AC, Dumitrescu A, Gereben B, Ribeiro MO, Fonseca TL, Fernandes GW, et al. Paradigms of dynamic control of thyroid hormone Signaling. Endocr Rev. 2019; 40: 1000-47. https://doi.org/10.1210/er.2018-00275.

[12] Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab. 2003; 88: 3202-11. https://doi.org/10.1210/jc.2002-022013.

[13] Dentice M, Ambrosio R, Damiano V, Sibilio A, Luongo C, Guardiola O, et al. Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression. Cell Metab. 2014; 20: 1038-48. https://doi.org/10.1016/j.cmet.2014.10.009.

[14] Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, Visser TJ, et al. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest. 2008; 118: 975-83. https://doi.org/10.1172/JCI32824.

[15] Peeters RP, van der Geyten S, Wouters PJ, Darras VM, van Toor H, Kaptein E, et al. Tissue thyroid hormone levels in critical illness. J Clin Endocrinol Metab. 2005; 90: 6498-507. https://doi.org/10.1210/jc.2005-1013.

[16] Pol CJ, Muller A, Zuidwijk MJ, van Deel ED, Kaptein E, Saba A, et al. Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. Endocrinology. 2011; 152: 669-79. https://doi.org/10.1210/en.2010-0431.

[17] Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V. Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab. 2001; 86: 4198-205.

[18] Rodriguez-Perez A, Palos-Paz F, Kaptein E, Visser TJ, Dominguez-Gerpe L, Alvarez-Escudero J, et al. Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clin Endocrinol. 2008; 68: 821-7. https://doi.org/10.1111/j.1365-2265.2007.03102.x.

[19] Dentice M, Luongo C, Huang S, Ambrosio R, Elefante A, Mirebeau-Prunier D, et al. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci USA. 2007; 104: 14466-71. https://doi.org/10.1073/pnas.0706754104.

[20] Sigafoos AN, Paradise BD, Fernandez-Zapico ME. Hedgehog/GLI Signaling pathway: transduction, regulation, and implications for disease. Cancers (Basel). 2021; 13: 13. https://doi.org/10.3390/cancers13143410.

[21] Wörmann SM, Song L, Ai J, Diakopoulos KN, Kurkowski MU, Görgülü K, et al. Loss of P53 function activates JAK2-STAT3 Signaling to promote pancreatic tumor growth, stroma modification, and gemcitabine resistance in mice and is associated with patient survival. Gastroenterology. 2016; 151: 180-93.e12. https://doi.org/10.1053/j.gastro.2016.03.010.

[22] Wajner SM, Goemann IM, Bueno AL, Larsen PR, Maia AL. IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J Clin Invest. 2011; 121: 1834-45. https://doi.org/10.1172/JCI44678.

[23] Vidart J, Wajner SM, Leite RS, Manica A, Schaan BD, Larsen PR, et al. N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trial. J Clin Endocrinol Metab. 2014; 99: 4537-45. https://doi.org/10.1210/jc.2014-2192.

[24] Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Lett. 2017; 387: 95-105. https://doi.org/10.1016/j.canlet.2016.03.042.

[25] Halsall DJ, Oddy S. Clinical and laboratory aspects of 3,3′,5′-triiodothyronine (reverse T3). Ann Clin Biochem. 2021; 58: 29-37. https://doi.org/10.1177/0004563220969150.

[26] Moura Neto A, Zantut-Wittmann DE. Abnormalities of thyroid hormone metabolism during systemic illness: the low T3 syndrome in different clinical settings. Int J Endocrinol. 2016; 2016: 2157583-9. https://doi.org/10.1155/2016/2157583.

[27] Ruhla S, Arafat AM, Weickert MO, Osterhoff M, Isken F, Spranger J, et al. T3/rT3-ratio is associated with insulin resistance independent of TSH. Horm Metab Res. 2011; 43: 130-4. https://doi.org/10.1055/s-0030-1267997.

[28] Beltrão FEL, Beltrão DCA, Carvalhal G, Beltrão FEL, Brito ADS, Capistrano K, et al. Thyroid hormone levels during hospital admission inform disease severity and mortality in COVID-19 patients. Thyroid. 2021; 31: 1639-49. https://doi.org/10.1089/thy.2021.0225.

[29] Boelen A, Kwakkel J, Alkemade A, Renckens R, Kaptein E, Kuiper G, et al. Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology. 2005; 146: 5128-34. https://doi.org/10.1210/en.2005-0608.

[30] Huang SA, Dentice M, Salvatore D, Desai A, Kellogg MD, Hartigan C, et al. Mice with hepatocyte-specific deficiency of type 3 deiodinase have intact liver regeneration and accelerated recovery from nonthyroidal illness after toxin-induced Hepatonecrosis. Endocrinology. 2014; 155: 4061-8. https://doi.org/10.1210/en.2013-2028.

[31] Kwakkel J, van Beeren HC, Ackermans MT, Platvoet-Ter Schiphorst MC, Fliers E, Wiersinga WM, et al. Skeletal muscle deiodinase type 2 regulation during illness in mice. J Endocrinol. 2009; 203: 263-70. https://doi.org/10.1677/JOE-09-0118.

[32] Fontes KN, Cabanelas A, Bloise FF, Andrade CBV, Souza LL, Wilieman M, et al. Differential regulation of thyroid hormone metabolism target genes during non-thyroidal illness syndrome triggered by fasting or sepsis in adult mice. Front Physiol. 2017; 8: 8. https://doi.org/10.3389/fphys.2017.00828.

[33] Agarwal S, Koh KH, Tardi NJ, Chen C, Dande RR, WerneckdeCastro JP, et al. Deiodinase-3 is a thyrostat to regulate podocyte homeostasis. EBioMedicine. 2021; 72: 103617. https://doi.org/10.1016/j.ebiom.2021.103617.

[34] Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017; 14: 39-55. https://doi.org/10.1038/nrcardio.2016.174.

[35] Wasyluk W, Zwolak A. Metabolic alterations in sepsis. J Clin Med. 2021; 10: 2412. https://doi.org/10.3390/jcm10112412.

[36] Bloise FF, Cordeiro A, Ortiga-Carvalho TM. Role of thyroid hormone in skeletal muscle physiology. J Endocrinol. 2018; 236: R57-r68. https://doi.org/10.1530/JOE-16-0611.

[37] Brunetto EL, Teixeira Sda S, Giannocco G, Machado UF, Nunes MT. T3 rapidly increases SLC2A4 gene expression and GLUT4 trafficking to the plasma membrane in skeletal muscle of rat and improves glucose homeostasis. Thyroid. 2012; 22: 70-9. https://doi.org/10.1089/thy.2010.0409.

[38] Gunst J, Verbruggen SC. Insulin resistance in critical illness: consequences for nutrition therapy and glucose management. Curr Opin Crit Care. 2023; 29: 286-92. https://doi.org/10.1097/MCC.0000000000001055.

[39] Batt J, Herridge MS, Dos Santos CC. From skeletal muscle weakness to functional outcomes following critical illness: a translational biology perspective. Thorax. 2019; 74: 1091-8. https://doi.org/10.1136/thoraxjnl-2016-208312.

[40] de Lange P, Senese R, Cioffi F, Moreno M, Lombardi A, Silvestri E, et al. Rapid activation by 3,5,3′-L-triiodothyronine of adenosine 5′-monophosphate-activated protein kinase/acetyl-coenzyme a carboxylase and akt/protein kinase B signaling pathways: relation to changes in fuel metabolism and myosin heavy-chain protein content in rat gastrocnemius muscle in vivo. Endocrinology. 2008; 149: 6462-70. https://doi.org/10.1210/en.2008-0202.

[41] Suh HN, Han HJ. Sonic hedgehog increases the skin wound-healing ability of mouse embryonic stem cells through the microRNA 200 family. Br J Pharmacol. 2015; 172: 815-28. https://doi.org/10.1111/bph.12947.

[42] Shi X, Wei S, Simms KJ, Cumpston DN, Ewing TJ, Zhang P. Sonic hedgehog Signaling regulates hematopoietic stem/progenitor cell activation during the Granulopoietic response to systemic bacterial infection. Front Immunol. 2018; 9: 349. https://doi.org/10.3389/fimmu.2018.00349.

[43] Sheng M, Lin Y, Xu D, Tian Y, Zhan Y, Li C, et al. CD47-mediated hedgehog/SMO/GLI1 Signaling promotes mesenchymal stem cell immunomodulation in mouse liver inflammation. Hepatology. 2021; 74: 1560-77. https://doi.org/10.1002/hep.31831.

[44] Lei W, Liu D, Sun M, Lu C, Yang W, Wang C, et al. Targeting STAT3: a crucial modulator of sepsis. J Cell Physiol. 2021; 236: 7814-31. https://doi.org/10.1002/jcp.30394.

[45] Yuan L, Zhang H, Liu J, Malhotra A, Dey A, Yu B, et al. STAT3 is required for Smo-dependent signaling and mediates Smo-targeted treatment resistance and tumorigenesis in Shh medulloblastoma. Mol Oncol. 2022; 16: 1009-25. https://doi.org/10.1002/1878-0261.13097.

[46] Wu L, Tan JL, Wang ZH, Chen YX, Gao L, Liu JL, et al. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway. J Mol Cell Cardiol. 2015; 81: 150-61. https://doi.org/10.1016/j.yjmcc.2015.02.015.

[47] Romitti M, Wajner SM, Ceolin L, Ferreira CV, Ribeiro RV, Rohenkohl HC, et al. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma. Endocr Relat Cancer. 2016; 23: 135-46. https://doi.org/10.1530/ERC-15-0162.

[48] van der Spek AH, Fliers E, Boelen A. Thyroid hormone and Deiodination in innate immune cells. Endocrinology. 2021; 162: bqaa200. https://doi.org/10.1210/endocr/bqaa200.